S. Manor

Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T‐cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real‐time quantitative polymerase chain reaction (RQ‐PCR)

I. Yaniv, S. Avigad, D. Luria, 2009, Pediatric blood & cancer.

Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?

E. Mejstrikova, O. Hrusak, E. Froňková, 2008, Leukemia.

Common, intermediate and well‐documented HLA alleles in world populations: CIWD version 3.0.0

A. Hajeer, M. Dudkiewicz, J. Mavrommatis, 2020, HLA.

Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens

A. Admon, D. Dominissini, A. Onn, 2022, Journal for ImmunoTherapy of Cancer.

Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation

M. Feinmesser, I. Yaniv, S. Avigad, 2007, Bone Marrow Transplantation.

Audits of collection and apheresis centers: guidelines by the World Marrow Donor Association Working Group Quality and Regulation

J. Pingel, P. Jindra, T. Torosian, 2018, Bone Marrow Transplantation.

East Meets West-Impact of Ethnicity on Donor Match Rates in the Ezer Mizion Bone Marrow Donor Registry.

I. Yaniv, A. Madbouly, M. Halagan, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population

S. Carmi, R. Balicer, Y. Louzoun, 2020, Journal of Clinical Immunology.

High-resolution HLA A∼B∼DRB1 haplotype frequencies from the Ezer Mizion Bone Marrow Donor Registry in Israel.

I. Yaniv, A. Madbouly, M. Halagan, 2016, Human immunology.

Identification and characterization of 122 novel HLA alleles in bone marrow donors recruited to the Ezer Mizion Bone Marrow Donor Registry.

N. Cereb, S. Manor, A. Bishara, 2022, HLA.

Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti‐E2‐antibody response

S. Dagan, Y. Shemer-Avni, N. Hilzenrat, 2004, Journal of medical virology.